CN109504689B - Transporter coding gene involved in regulating and controlling ACT yield in streptomycete - Google Patents
Transporter coding gene involved in regulating and controlling ACT yield in streptomycete Download PDFInfo
- Publication number
- CN109504689B CN109504689B CN201910040375.3A CN201910040375A CN109504689B CN 109504689 B CN109504689 B CN 109504689B CN 201910040375 A CN201910040375 A CN 201910040375A CN 109504689 B CN109504689 B CN 109504689B
- Authority
- CN
- China
- Prior art keywords
- yield
- act
- gene
- genes
- streptomyces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 98
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 14
- 230000001276 controlling effect Effects 0.000 title claims abstract description 9
- 241001655322 Streptomycetales Species 0.000 title claims description 16
- 241000187432 Streptomyces coelicolor Species 0.000 claims abstract description 18
- 230000033228 biological regulation Effects 0.000 claims abstract description 18
- 241000187747 Streptomyces Species 0.000 claims abstract description 12
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 206010064571 Gene mutation Diseases 0.000 claims abstract 2
- 230000002779 inactivation Effects 0.000 claims description 19
- 230000035772 mutation Effects 0.000 claims description 15
- 102000014914 Carrier Proteins Human genes 0.000 claims 2
- VTIKDEXOEJDMJP-UHFFFAOYSA-N Actinorhodine Natural products CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)c(cc(O)c3C2=O)c4cc(O)c5C(=O)C6=C(C(C)OC(CC(=O)O)C6)C(=O)c5c4O VTIKDEXOEJDMJP-UHFFFAOYSA-N 0.000 abstract description 75
- VTIKDEXOEJDMJP-WYUUTHIRSA-N actinorhodin Chemical compound C([C@@H](CC(O)=O)O[C@@H]1C)C(C(C2=C(O)C=3)=O)=C1C(=O)C2=C(O)C=3C(C(=C1C2=O)O)=CC(O)=C1C(=O)C1=C2[C@@H](C)O[C@H](CC(O)=O)C1 VTIKDEXOEJDMJP-WYUUTHIRSA-N 0.000 abstract description 75
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 238000012216 screening Methods 0.000 abstract description 8
- 238000000855 fermentation Methods 0.000 abstract description 4
- 230000004151 fermentation Effects 0.000 abstract description 4
- 238000012163 sequencing technique Methods 0.000 abstract description 4
- 238000001976 enzyme digestion Methods 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 229930001119 polyketide Natural products 0.000 abstract description 3
- 150000003881 polyketide derivatives Chemical class 0.000 abstract description 3
- 230000002269 spontaneous effect Effects 0.000 abstract description 2
- 230000014509 gene expression Effects 0.000 description 26
- 238000012224 gene deletion Methods 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 230000017105 transposition Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 229930000044 secondary metabolite Natural products 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 244000005700 microbiome Species 0.000 description 8
- 238000002703 mutagenesis Methods 0.000 description 8
- 231100000350 mutagenesis Toxicity 0.000 description 8
- 238000011160 research Methods 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 101100072546 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) ilvD gene Proteins 0.000 description 5
- 101100454597 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) leuA gene Proteins 0.000 description 5
- 101100458219 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) mshA gene Proteins 0.000 description 5
- 101100238632 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) mshC gene Proteins 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 4
- 229950006334 apramycin Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000003827 upregulation Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 101100083167 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) pglZ gene Proteins 0.000 description 3
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 description 3
- 230000037354 amino acid metabolism Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000001627 detrimental effect Effects 0.000 description 3
- 230000003828 downregulation Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000024053 secondary metabolic process Effects 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 108010030975 Polyketide Synthases Proteins 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Chemical compound OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 108010021680 2-oxoglutarate decarboxylase Proteins 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- CFYSVTOSOGSISU-UHFFFAOYSA-N COC1=C(N=C(N=C1OC)NCC2=CC=CC=C2)OC Chemical compound COC1=C(N=C(N=C1OC)NCC2=CC=CC=C2)OC CFYSVTOSOGSISU-UHFFFAOYSA-N 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- HIYSWASSDOXZLC-UHFFFAOYSA-N Undecylprodigiosin Natural products CCCCCCCCCCCc1ccc(C=C2N=C(C=C2OC)c2ccc[nH]2)[nH]1 HIYSWASSDOXZLC-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005621 mannosylation reaction Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- HIYSWASSDOXZLC-HKOYGPOVSA-N undecylprodigiosin Chemical compound N1C(CCCCCCCCCCC)=CC=C1\C=C\1C(OC)=CC(C=2NC=CC=2)=N/1 HIYSWASSDOXZLC-HKOYGPOVSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The application belongs to the technical field of microbial fermentation engineering, and particularly relates to a gene related to the yield of Actinorhodin (ACT) of a polyketide in streptomyces. The application particularly relates to the application of transporter genes in the aspect of regulating and controlling the yield of the streptomyces ACT, wherein the number of transporter coding genes is 6; the method comprises the following steps:SCO2254、SCO2534、SCO3765、SCO6160、SCO2519、SCO3185(ii) a After the gene mutation, the gene has regulation and control influence on the yield of streptomyces ACT. The inventors have mutagenized Streptomyces coelicolor M145 and screened strains with altered actinorhodin production. And (3) positioning the position of the transposon on the genome of the screened positive clone by enzyme digestion, self-ligation and sequencing, eliminating spontaneous mutant genes by the principle of repeatedly screening and positioning the same gene, and finally determining the gene influencing the yield of the actinorhodin.
Description
Technical Field
The application belongs to the technical field of microbial fermentation engineering, and particularly relates to a gene related to the yield of Actinorhodin (ACT) of a polyketide in streptomyces.
Background
The existing research generally considers that small molecular compounds generated by the secondary metabolism of microorganisms have important significance on human health. Statistics indicate that more than 60% of the current FDA-approved anti-infective and anti-tumor drugs are derived from microbial secondary metabolites. As more and more genome sequencing work of microorganisms is carried out, genome sequence analysis shows that the microorganisms have great potential for generating various secondary metabolites, but partial research shows that many secondary metabolites of the microorganisms cannot be expressed under the laboratory culture condition, and most environmental microorganisms cannot be effectively cultured under the laboratory condition, so that the development of the secondary metabolites of the microorganisms is seriously hindered.
In the existing research, streptomyces is an important antibiotic producing bacterium, and the production of the antibiotic is controlled by environmental signals and self-regulating genes. The streptomyces coelicolor is a model strain for researching the differentiation and secondary metabolism of streptomyces and can produce two colored antibiotics actinorhodin (ACT blue) and undecylprodigiosin (Red Red), and ACT and RED synthetases belong to type I polyketide synthase (I-PKS) and type II polyketide synthase (II-PKS), respectively. The 2 secondary metabolites in the streptomyces coelicolor are used as a model for researching the synthesis and regulation of the secondary metabolism of the streptomyces coelicolor, and aiming at the screening of the 2 secondary metabolite regulation genes, a good foundation can be laid for the genetic modification of antibiotic producing bacteria, the yield improvement of antibiotic industrial strains or the activation and expression of silent gene clusters.
In the prior art, the inventor uses transposition mutagenesis technology to research the functional genome of streptomyces coelicolor A3(2) in early stage and initially constructs a streptomyces coelicolor A (3)2 mutant library (specifically, refer to Xuzhong, research the functional genome of streptomyces coelicolor A3(2) by using transposition mutagenesis, 2011 university of Master thesis in Huazhong agriculture), but because of complexity and uncertainty of related gene regulation functions, further intensive research and discussion are needed for specific genes related to regulation of secondary metabolites.
Disclosure of Invention
The application aims to provide the screened part of genes related to ACT metabolic regulation in microorganisms, thereby laying a foundation for the research of streptomycete secondary metabolites and the development of novel drugs.
The technical solution adopted in the present application is described in detail as follows.
Genes influencing ACT yield in streptomycete, wherein the genes have a regulating and controlling effect in the synthesis of a streptomycete polyketide ACT; examples of the microorganism include Streptomyces coelicolor (S. coelicolor)Streptomyces coelicolor) (ii) a The above-mentionedGenes are classified into four major groups according to their existing gene annotation, specifically:
cells are synthesized in regulatory classes:
a total of 7, including genesSCO1525、SCO2097、SCO2132、SCO3150、SCO4440、SCO4878、SCO5174(ii) a According to the existing gene annotation, in particular:
SCO1525 and SCO2132 are involved in cell wall phosphatidylinositol mannosylation modification;
SCO2097 is involved in cell wall synthesis;
SCO3150 is involved in cell lysis;
SCO4440 is involved in cell membrane phosphatidylinositol signal regulation;
SCO4878 and SCO5174 are involved in cell wall glycosylation modification;
in the present application, after the mutation (gene deletion or inactivation) of the gene, the expression level (yield) of ACT is decreased, in other words, the gene has a positive regulation effect on the expression level (yield) of ACT; that is, after the gene is mutated (gene deletion or inactivation), the expression quantity (yield) of the ACT is reduced, and after the copy number of the gene is increased or the gene is over-expressed, the gene has the potential of regulating the expression quantity (yield) of the ACT;
amino acid metabolism classes:
7 in total; involving association with amino acid metabolismSCO2241、SCO2528、SCO3345、SCO5281、SCO5512、SCO2999、SCO3962(ii) a According to the existing gene annotation, in particular:
SCO2241 participates in the synthesis of glutamic acid;
SCO2528 is involved in leucine synthesis;
SCO3345 is involved in the synthesis of valine and isoleucine;
SCO5281 α -ketoglutarate decarboxylase;
SCO5512 is involved in branched amino acid metabolism;
the SCO2999 is involved in the metabolism of glutamic acid,
SCO3962 is involved in prephenate metabolism;
in the present application, after the mutation of the gene (gene deletion or inactivation), the gene has uncertain regulation and control effects on ACT expression level (yield), and further:
SCO2241、SCO2528、SCO3345、SCO5281andSCO5512after any one of the 5 genes is mutated (gene deletion or inactivation), the expression level (yield) of ACT is reduced, in other words, the 5 genes have positive regulation effect; that is, any one of the 5 genes can regulate and control the reduction of the expression quantity (yield) of the ACT after mutation (gene deletion or inactivation), and has the potential of regulating and controlling the increase of the expression quantity (yield) of the ACT after the copy number of the gene is increased or the gene is over-expressed;
SCO2999andSCO3962after any one of the 2 genes is mutated (gene deletion or inactivation), the expression level (yield) of ACT is increased, in other words, the 2 genes have a negative regulation effect; that is, any of the 2 genes can regulate the increase of the expression level (yield) of the ACT after mutation (gene deletion or inactivation), and the possibility of regulating the decrease of the expression level (yield) of the ACT can be realized after the copy number of the genes is increased or even the genes are over-expressed;
stress, signal and transcriptional regulation classes:
a total of 14, including genes:SCO0871、SCO1663、SCO2832、SCO2987、SCO3571、SCO4204、SCO4215、SCO4358、SCO6994、SCO1728、SCO2686、SCO3008、SCO5220、SCO6636；
according to the existing gene annotation, in particular:
the SCO0871 participates in the regulation of signals,
SCO1663, SCO4204 and SCO2987 participate in environmental stress regulation,
SCO2832, SCO3571, SCO4215, SCO4358, SCO6994, SCO1728, SCO2686, SCO3008, SCO5220 and SCO6636 are transcription regulation proteins;
in the present application, after the mutation of the gene (gene deletion or inactivation), the gene has uncertain regulation and control effects on ACT expression level (yield), and further:
SCO0871、SCO1663、SCO2832、SCO2987、SCO3571、SCO4204、SCO4215、SCO4358andSCO6994after any one of the 9 genes is mutated (gene deletion or inactivation), the expression level (yield) of ACT is reduced, in other words, the 9 genes have positive regulation effect; that is, any one of the 9 genes can regulate and control the reduction of the expression quantity (yield) of the ACT after mutation (gene deletion or inactivation), and has the potential of regulating and controlling the increase of the expression quantity (yield) of the ACT after the copy number of the gene is increased or the gene is over-expressed;
SCO1728、SCO2686、SCO3008、SCO5220andSCO6636after any one of the 5 genes is mutated (gene deletion or inactivation), the expression level (yield) of ACT is increased, in other words, the 5 genes have negative regulation effect; that is, any of the 5 genes can regulate the increase of the expression level (yield) of the ACT after mutation (gene deletion or inactivation), and the regulation of the expression level (yield) of the ACT can be reduced after the genes are complemented back, copy number is increased or overexpressed;
transporters:
6 in total; the method comprises the following steps:SCO2254、SCO2534、SCO3765、SCO6160、SCO2519、SCO3185(ii) a According to the existing gene annotation, in particular:
SCO2254 is a transmembrane channel protein;
SCO2534, SCO3765 and SCO3185 participate in ion transport;
SCO2519 is involved in lipid transport and antibiotic efflux;
SCO6160 is involved in protein transport;
in the present application, after the mutation of the gene (gene deletion or inactivation), the gene has uncertain regulation and control effects on ACT expression level (yield), and further:
SCO2254、SCO2534、SCO3765andSCO6160after mutation (gene deletion or inactivation) of any of these 4 genes, the ACT expression level (yield) is decreased, in other words, these 4 genesThe product has positive regulation and control effect; that is, any one of the 4 genes can regulate and control the reduction of the expression quantity (yield) of the ACT after mutation (gene deletion or inactivation), and has the potential of regulating and controlling the increase of the expression quantity (yield) of the ACT after the copy number of the gene is increased or the gene is over-expressed;
SCO2519andSCO3185after any one of the 2 genes is mutated (gene deletion or inactivation), the expression level (yield) of ACT is increased, in other words, the 2 genes have a negative regulation effect; that is, any of these 2 genes may regulate the increase of the expression level (yield) of ACT after mutation (gene deletion or inactivation), and may regulate the decrease of the expression level (yield) of ACT after complementation, copy number increase, or overexpression of the gene.
In the application, in order to systematically excavate a series of genes influencing and controlling the yield of Actinorhodin (ACT) in an antibiotic-producing strain streptomyces coelicolor, the inventor adopts an in-vivo transposition system based on mini-Tn5 to mutate streptomyces coelicolor M145 and further screens strains with variable Actinorhodin yield. The experimental results show that: the vector (pHL 734) used in the mutagenesis system does not contain a Streptomyces replicon and an integration site, and only one transposition event can occur after the vector is transferred into a Streptomyces cell by conjugation, so that each positive clone genome screened only contains one randomly inserted mini-Tn5 copy. And further positioning the position of the transposon on the genome of the screened positive clone by enzyme digestion, self-ligation and sequencing, and eliminating a spontaneous mutant gene by the principle of repeatedly screening and positioning the same gene, thereby finally determining the gene influencing the yield of the actinorhodin. Further taking the wild type strain as a reference, and finally determining that the related genes influence the yield of the actinorhodin through fermentation culture. Based on the screening results, a foundation can be laid for the regulation of the yield of related metabolites or the synthesis of new secondary metabolites by further using a genetic engineering technical means.
Detailed Description
The present application is further illustrated by the following examples. Before describing the specific embodiments, a brief description will be given of some experimental background cases in the following embodiments.
Biological material:
streptomyces coelicolor M145 (Streptomyces coelicolor M145) (prototrophic wild type strain A3 (2)) as a transposable mutagenesis starting strain;
escherichia coli ET12567/pUZ8002 (Escherichia coliET12567/pUZ 8002) for introducing plasmid pHL734 into streptomyces coelicolor M145;
plasmid pHL734 carries transposable element Mini-Tn5 and transposase, and is used for transposable mutagenesis of Streptomyces coelicolor M145;
experimental reagent:
LB culture medium is used for culturing Escherichia coli at 37 ℃;
YEME culture medium and TSBY culture medium are used for culturing streptomycete liquid,
adding MgSO (MgSO) into SFM medium4(20 mM) for conjugal transfer of Streptomyces;
the YBP culture medium is used for streptomycete solid culture and fermentation, and the culture temperature of the streptomycete is 30 ℃;
apramycin (Apramycin, Apr), resistance geneAcc(3)IVThe use concentration is 50 mug/mL;
trimethoxybenzylaminopyrimidine (TMP) was used at a concentration of 50. mu.g/mL.
Example 1
This example is briefly described below with respect to the mutagenesis procedure of S.coelicolor M145 using the mini-Tn5 transposition system. It should be noted that the detailed process is described in "study of functional genome of Streptomyces coelicolor A3(2) by transposable mutagenesis" (Xuzhong, 2011 Master thesis at Huazhong university of agriculture).
Transposons transposable mutagenesis of Streptomyces coelicolor
Firstly, referring to the prior art, a transposon plasmid pHL734 is introduced into streptomycete by conjugal transfer of an escherichia coli strain ET12567/pUZ8002 and streptomyces coelicolor, and the ratio of recipient bacteria to donor bacteria is 1: 1;
theoretically, after entering the streptomycete, the transposase Tnp (5) starts to express, the mini-Tn5 fragment is cut and randomly inserted into the genome of the streptomycete, and the plasmid disappears after the transposition occurs because the plasmid cannot replicate and integrate sites in the streptomycete;
covering the cells with TMP and Apr (screening mutants with transposition insertion through an apramycin resistance gene inside Mini-Tn 5) about 12-14 hours after conjugation transfer, and culturing for about 4-5 days; the resulting conjugative transfer clones were transferred to YBP medium (each mutant contains a transposition insert) and mutants with varying secondary metabolite production were selected.
(II) transposition insertion mapping of mutant strains
Respectively extracting the total DNA of the mutant strain with the change of the secondary metabolite yield in the step (I), and carrying out enzyme digestion on the total DNA by using ApaI restriction enzyme;
introducing the digested DNA sample into escherichia coli DH5 alpha through self-ligation and chemical transformation;
screening clone containing mini-Tn5 fragment by using apramycin, sequencing to obtain genome sequences at two ends of mini-Tn5 and a transposition insertion site thereof, and positioning the position of the transposition insertion on a chromosome through sequence comparison.
(III) complementation of mutant strains
Selecting 5 genes related to transcription regulationSCO2832、SCO4215、SCO4358、SCO2686AndSCO3008the back-supplementing verification is carried out,
CDS of the genes and upstream 250 bp promoter region sequences thereof are amplified by PCR and connected to a streptomycete integration vector pMT3, after the sequencing is verified to be correct, escherichia coli ET12567/pUZ8002 is transformed and transferred into a streptomycete mutant strain through the joint of the escherichia coli and the streptomycete;
after the genome of the 5-gene mutant strain is respectively introduced with corresponding normal gene copies, the actinorhodin yield is restored to the wild level, which shows that the regulation and control of the actinorhodin yield by the genes repeatedly screened for many times are 100 percent correct.
(IV) determination of ACT production by mutant strains
The transposable mutant and the original strain are respectively cultured in solid YBP for 84 hours at 30 ℃, and 0.5 g of each culture product is used for ACT yield determination; ACT yield determination:
0.5 mL of 1M NaOH was added to 0.5 g of the culture product, disrupted by a homogenizer (5,000 rpm, 15 s; twice), centrifuged (12000 Xg, 5 min) to take the supernatant, and the absorbance of the supernatant was measured by UV ray at 633 nm to obtain the relative yield of ACT of the Mutant strain (Mutant 633/WT 633).
Example 2
This example is briefly described below with respect to the screening results of example 1.
On the basis of the screening method of example 1, 988 strains with changed actinorhodin production were screened from 50000 mutants as a result, and the transposition insertion sites of the strains were located to show that the mutant strains relate to 551 genes; some of the genes having a regulatory effect on the production of actinorhodin are specifically explained below.
Cells are synthesized in regulatory classes:
a total of 7, including genesSCO1525、SCO2097、SCO2132、SCO3150、SCO4440、SCO4878、SCO5174；
Note (the following tabular data are synonymous and will not be described): in the table, relative ACT yields indicate the ratio of ACT yields of mutant to wild-type, less than 1 indicates a reduced ACT yield of the mutant, 0 indicates no ACT production was detected, and values are "spaced" to indicate multiple mutant strains of the same gene, which have different mini-Tn5 insertion sites in the gene.
Note that, in the above table data, the annotation contents are obtained by integrating StrepDB data (http:// StrepDB. streptomyces. org. uk) and literature reports; ACT relative yields were calculated from the mean values for each mutant (data in the tables below are synonymous and are not described).
Analysis of the data in the above table shows that the actinorhodin production is reduced after 7 cells are inactivated by genes related to synthesis, which indicates that the integrity of the cell envelope is necessary for the synthesis of ACT, and the mutation (inactivation) of the genes has a positive correlation with the actinorhodin production.
Amino acid metabolism classes:
7 in total; involving association with amino acid metabolismSCO2241、SCO2528、SCO3345、SCO5281、SCO5512、SCO2999、SCO3962；
Analysis can see that:
SCO2241、SCO2528、SCO3345、SCO5281andSCO5512all mutant strains of the genes had reduced ACT production, indicating that the products encoded by these genes favor ACT synthesis,
whileSCO2999AndSCO3962all mutant strains of the genes showed elevated ACT production, indicating that the encoded products of these genes are detrimental to ACT synthesis.
Stress, signal and transcriptional regulation classes:
a total of 14, including genesSCO0871、SCO1663、SCO2832、SCO2987、SCO3571、SCO4204、 SCO4215、SCO4358、SCO6994、SCO1728、SCO2686、SCO3008、SCO5220、SCO6636；
Analysis can see that:
SCO0871、SCO1663、SCO2832、SCO2987、SCO3571、SCO4204、SCO4215、SCO4358andSCO6994all mutant strains of the genes have reduced ACT yield, which indicates that the coded products of the genes are favorable for ACT synthesis;
SCO1728、SCO2686、SCO3008、SCO5220andSCO6636all mutant strains of the genes showed elevated ACT production, indicating that the encoded products of these genes are detrimental to ACT synthesis.
Transporters:
a total of 6, including genesSCO2254、SCO2534、SCO3765、SCO6160、SCO2519、SCO3185；
Analysis can see that:
SCO2254、SCO2534、SCO3765andSCO6160all mutant strains of the genes have reduced ACT yield, which indicates that the coded products of the genes are favorable for ACT synthesis;
SCO2519andSCO3185all mutant strains of the genes showed elevated ACT production, indicating that the encoded products of these genes are detrimental to ACT synthesis.
In conclusion, based on the effect of the different genes on the yield of ACT, one or more of the genes can be subjected to independent mutation or combined mutation to inactivate the genes, or overexpression is performed by using transgenic engineering, so that the yield of ACT is specifically regulated, and the production performance of antibiotics is further improved.
Claims (1)
1. The application of the transport protein coding gene in the aspect of regulating and controlling the yield of the streptomycete ACT is characterized in that the number of the transport protein coding genes is 5; the method comprises the following steps: SCO2254, SCO2534, SCO3765, SCO6160, SCO 2519;
after the gene mutation, the gene has regulation and control influence on the yield of streptomyces ACT;
the regulation and control influence is specifically as follows:
after any one of the 4 genes SCO2254, SCO2534, SCO3765 and SCO6160 is inactivated and mutated, the ACT yield is reduced;
after the inactivation and mutation of the SCO2519 gene, the yield of ACT is increased;
the streptomyces is streptomyces coelicolor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910040375.3A CN109504689B (en) | 2019-01-16 | 2019-01-16 | Transporter coding gene involved in regulating and controlling ACT yield in streptomycete |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910040375.3A CN109504689B (en) | 2019-01-16 | 2019-01-16 | Transporter coding gene involved in regulating and controlling ACT yield in streptomycete |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109504689A CN109504689A (en) | 2019-03-22 |
| CN109504689B true CN109504689B (en) | 2021-09-17 |
Family
ID=65758024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910040375.3A Active CN109504689B (en) | 2019-01-16 | 2019-01-16 | Transporter coding gene involved in regulating and controlling ACT yield in streptomycete |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109504689B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5876987A (en) * | 1996-02-07 | 1999-03-02 | Board Of Trustees Operating Michigan State University | Method, DNA and bacteria for hyperproduction of an antibiotic due to disruption of an AbsA gene |
| CN102181470A (en) * | 2011-03-08 | 2011-09-14 | 上海交通大学 | Method for improving yield of Streptomyces antibiotics and plasmid thereof |
| KR20120019334A (en) * | 2010-08-25 | 2012-03-06 | 인하대학교 산학협력단 | Antibiotics-productivity enhancing method by genetically controlling antibiotic down-regulator genes of streptomyces sp |
| CN102634523A (en) * | 2011-04-18 | 2012-08-15 | 河北农业大学 | Negative regulation gene of streptomyces roseoflavus as well as preparation method and application thereof |
| CN104109688A (en) * | 2014-07-23 | 2014-10-22 | 南通大学 | Method for randomly knocking out streptomyces genome DNA large fragment in vivo |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2466340C (en) * | 2003-01-21 | 2007-07-10 | Ecopia Biosciences Inc. | Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
-
2019
- 2019-01-16 CN CN201910040375.3A patent/CN109504689B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5876987A (en) * | 1996-02-07 | 1999-03-02 | Board Of Trustees Operating Michigan State University | Method, DNA and bacteria for hyperproduction of an antibiotic due to disruption of an AbsA gene |
| KR20120019334A (en) * | 2010-08-25 | 2012-03-06 | 인하대학교 산학협력단 | Antibiotics-productivity enhancing method by genetically controlling antibiotic down-regulator genes of streptomyces sp |
| CN102181470A (en) * | 2011-03-08 | 2011-09-14 | 上海交通大学 | Method for improving yield of Streptomyces antibiotics and plasmid thereof |
| CN102634523A (en) * | 2011-04-18 | 2012-08-15 | 河北农业大学 | Negative regulation gene of streptomyces roseoflavus as well as preparation method and application thereof |
| CN104109688A (en) * | 2014-07-23 | 2014-10-22 | 南通大学 | Method for randomly knocking out streptomyces genome DNA large fragment in vivo |
Non-Patent Citations (4)
| Title |
|---|
| "Genome-Wide Mutagenesis Links Multiple Metabolic Pathways with Actinorhodin Production in Streptomyces coelicolor";Zhong Xu等;《Applied and Environmental Microbiology》;20190201;第85卷(第7期);第1-13页 * |
| "Increasing Avermectin Production in Streptomyces avermitilis by Manipulating the Expression of a Novel TetR-Family Regulator and Its Target Gene Product";Wenshuai Liu等;《Applied and Environmental Microbiology》;20150522;第81卷(第15期);第5157-5173页 * |
| "Large-scale transposition mutagenesis of Streptomyces coelicolor identifies hundreds of genes influencing antibiotic biosynthesis";Zhong Xu等;《Applied and Environmental Microbiology》;20170106;第83卷(第6期);第1-16页 * |
| "天蓝色链霉菌代谢物组测定方法优化及其代谢特征";李宜鸿等;《生物工程学报》;20131203;第30卷(第4期);第554-568页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109504689A (en) | 2019-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van Lanen et al. | Microbial genomics for the improvement of natural product discovery | |
| Aranda et al. | A rapid and simple method for constructing stable mutants of Acinetobacter baumannii | |
| Nah et al. | Precise cloning and tandem integration of large polyketide biosynthetic gene cluster using Streptomyces artificial chromosome system | |
| CN104561050A (en) | Genes encoding biofilm formation inhibitory proteins and method for producing L-lysine using bacterial strain with the inactivated genes | |
| Lennen et al. | Combinatorial strategies for improving multiple-stress resistance in industrially relevant Escherichia coli strains | |
| Stella et al. | Biosensor-based isolation of amino acid-producing Vibrio natriegens strains | |
| CN109666617A (en) | The production bacterial strain and its construction method of a kind of L- homoserine and application | |
| CN110741091A (en) | Genome engineering of biosynthetic pathways to increase NADPH | |
| O’Connor | tRNA imbalance promotes− 1 frameshifting via near-cognate decoding | |
| Tian et al. | The genome and transcriptome of Lactococcus lactis ssp. lactis F44 and G423: insights into adaptation to the acidic environment | |
| Ye et al. | Transcriptome-guided identification of a four-component system, SbrH1-R, that modulates milbemycin biosynthesis by influencing gene cluster expression, precursor supply, and antibiotic efflux | |
| Gehlert et al. | Active in vivo translocation of the Methanosarcina mazei Gö1 Casposon | |
| JPS59501532A (en) | Plasmids with conditionally uncontrolled replication behavior | |
| CN109504689B (en) | Transporter coding gene involved in regulating and controlling ACT yield in streptomycete | |
| CN109679980B (en) | Amino acid metabolism gene involved in regulating and controlling ACT yield in streptomycete | |
| CN109504690B (en) | Stress, signal and transcription regulation gene involved in regulating and controlling yield of streptomycete ACT | |
| CN109679969B (en) | Cellular synthesized genes involved in regulating ACT production in Streptomyces | |
| CN108251344A (en) | The structure of the serial efficient heterogenous expression host of streptomyces coelicolor and application | |
| Lin et al. | Combined transcriptomic and pangenomic analyses guide metabolic amelioration to enhance tiancimycins production | |
| Kroll et al. | Establishment of a novel anabolism-based addiction system with an artificially introduced mevalonate pathway: complete stabilization of plasmids as universal application in white biotechnology | |
| Yang et al. | Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization | |
| EP4273251A1 (en) | Recombinant bacillus sp. microorganism and method for producing human milk oligosaccharides using same | |
| EP4137576A1 (en) | Chromosomal integrating cassette allowing inducible gene expression for production of compounds via fermentation | |
| JPS6158595A (en) | Scale production of protein by microorganism | |
| CN107810269A (en) | Novel promoter and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |